Mercury toxicity and systemic elimination agents

Journal of Nutritional and Environmental Medicine

Volumn 11, Issue 1, 2001, Pages 53-62

  Mercola, Joseph ^a   Klinghardt, Dietrich ^b  

^a Optimal Wellness Center   (United States)

^b American Acad of Neural Therapy   (United States)

Author keywords

Amalgam and mercury toxicity; Chlorella; Cilantro; DMPS; DMSA

Indexed keywords

AMALGAM; MERCURY; SUCCIMER; UNITHIOL;

CHLORELLA; CONTAMINATION; DENTAL SURGERY; ELECTRIC CONDUCTIVITY; HUMAN; HUMAN CELL; MERCURIALISM; NEUROTRANSMITTER RELEASE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SOLUBILITY;

EID: 0035075954     PISSN: 13590847     EISSN: None     Source Type: Journal    
DOI: 10.1080/13590840020030267     Document Type: Review

References (126)

1. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants
2. Mercury, infant neurodevelopment, and vaccination
3. Preventing harm from thimerosal in vaccines
4. Recommendations regarding the use of vaccines that contain thimerosal as a preservative
5. Placental transfer of methylmercury and mercuric mercury in mice
6. Maternal and cord blood background levels. A longitudinal surveillance
7. Some electrochemical features of the in vivo corrosion of dental amalgams
8. Dissolution of mercury vapor in simulated oral environments
9. Human exposure to mercury and silver released from dental amalgam restorations
10. Almost two centuries with amalgam. Where are we today?
11. Mercury exposure from "silver" tooth fillings: Emerging evidence questions a traditional dental paradigm
12. Evaluation of the safety issue of mercury release from dental fillings
13. Mercury in saliva and feces after removal of amalgam fillings
14. The effects of dental amalgams on mercury levels in expired air
15. Intra-oral air mercury released from dental amalgam
16. Dental amalgam and mercury
17. The dental amalgam issue. A review
18. Molecular interactions with mercury in the kidney
19. Whole-body imaging of the distribution of mercury released from dental fillings into monkey tissues
20. Abgabe von quecksilberdampf aus dentalamalgamen unter mundbedingungen
21. Delayed cerebellar disease and death after accidental exposure to dimethylmercury
22. Mercury - An element of mystery
23. Correlation of dental amalgam with mercury in the brain
24. Retrograde axonal transport of mercury
25. Inorganic mercury is transported from muscular nerve terminals to spinal and brainstem motomeurons
26. Mercury
27. Heavy metals and heavy-metal antagonists
28. Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: Similarity to a molecular lesion in Alzheimer diseased brain
29. Inhibition of brain tubulin-guanosine 5′-triphosphate interactions by mercury: Similarity to observations in Alzheimer's diseased brain
30. Production of monoclonal antibodies
31. Adverse immunological effects and autoimmunity induced by dental amalgam and alloy in mice
32. Autoimmunity and heavy metals
33. Mercury concentrations in the human brain and kidneys in relation to exposure from dental amalgam fillings
34. Therapy of immunologic infertility
35. The effect of occupational exposure to mercury vapor on the fertility of female dental assistants
36. Heavy metals and fertility
37. Diagnosis of mercury body burden
38. Mercury induces GTP-tubulin interactions in rat brain similar to those observed in Alzheimer's disease
39. Adverse immunological effects and autoimmunity induced by dental amalgam and alloy in mice
40. Evidence that mercury from silver dental fillings may be an etiological factor in reduced nerve conduction velocity in multiple sclerosis patients
41. Endocrine function in mercury exposed chloralkali wokers
42. Lymphocytes T and NK cells in men occupationally exposed to mercury vapors
43. Mercury released from dental silver fillings provokes an increase in mercury and antibiotic-resistant bacteria in oral and intestinal floras of primates
44. Behavioral effects of low level exposure to mercury among dentists
45. Chronic neurobiological effects of elemental mercury in dentists
46. The relationship between mercury from dental amalgam and mental health
47. Changes in the incidence of childhood autism and other autistic spectrum disorders in preschool children from two areas of the West Midlands, UK
48. Pervasive developmental disorders: A 10-year review
49. Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models
50. Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy
51. Subclinical neurotoxicity of mercury vapor revealed by a multimodality evoked potential study of chloralkali workers
52. Chronic elemental mercury intoxication: Clinical and field studies in lampsocked manufacturers
53. Elemental mercury vapour toxicity, treatment and prognosis after acute intensive exposure in chloraklali plant workers. Part II. History, neuropsychological findings and chelator effects
54. Mercury
55. The future of dental amalgam: A review of the literature. Part 2: Mercury exposure in dental practice
56. Synthesis and properties of demercapto derivatives of alkylsulfonic acids
57. Evaluation of urinary mercury excretion after administration of 2,3-dimercapto-l-propane sulfonic acid to occupationally exposed men
58. Treatment of mercury and lead poisonings with dimercaptosuccinic acid and sodium dimercaptopropanesulfonate
59. Human studies with the chelating agents, DMPS and DMSA
60. Meso-2,3 dimercaptosuccinic acid: Chemical, pharmacological and toxicological properties of an orally effective metal chelating agent
61. Evaluation of the safety issue of mercury release from dental fillings
62. Mobilization of mercury and arsenic in humans by sodium 2,3 dimercapto-l-propane Sulfonate (DMPS)
63. Environmental medicine, part three: Long-term effects of chronic low-dose mercury exposure
64. Mobilization of mercury reserves in the organism by means of DMPS
65. Results of dental amalgam removal and mercury detoxification using DMPS and neural therapy
66. Assessment of the protective activity of monisoamyl meso-2,3-dimercaptosuccinate against methylmercury-induced maternal and embryo/fetal toxicity in mice
67. Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization in rats
68. Schadstoffe und Fertiliatatsstorungen Schwermetalle und Mineralstoffe
69. Treatment of mercury intoxication
70. Diagnostic value of a chelating agent in patients with symptoms allegedly caused by amalgam fillings
71. Clearance half life of mercury in urine after the cessation of long term occupational exposure: Influence of a chelating agent (DMPS) on excretion of mercury in urine
72. Zinc protection of mercury-induced hepatic toxicity in mice
73. Mobilization of heavy metals by newer, therapeutically useful chelating agents
74. Sodium 2,3-dimercaptopropane-l-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico
75. Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats
76. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity
77. Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-l-propanesulfonate after intravenous administration to human volunteers
78. Determination and metabolism of dithiol chelating agents
79. Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-l-propane sulfonate
80. The binding of heavy metals to algal surfaces
81. Phytochelatin production in marine algae: An interspecies comparison
82. Characterization of the cadmium-binding capacity of Chlorella vulgaris
83. Biosorption of radioactive species
84. Amalgam/mercury detox as a treatment for chronic viral, bacterial, and fungal illnesses
85. Chitin and chitosan on chromatographic supports and adsorbents for collection of metal ions from organic and aqueous solutions and sea water
86. Mechanism of metal ion binding to chitosan in solution, cooperative inter- and intramolecular chelations
87. Role of mercury (Hg) in resistant infections and effective treatment of Chlamydia trachomatis and Herpes family viral infections (and potential treatment for cancer) by removing localized Hg deposits with Chinese parsley and delivering effective antibiotics using various drug uptake enhancement methods
88. Increased inorganic mercury in spinal motor neurons following chelating agents
89. A study on the effect of garlic to the heavy metal poisoning of rat
90. Protective effects of garlic juice against embryotoxicity of methylmercuric chloride administered to pregnant Fischer 344 rats
91. Garlic as an insect repellent
92. Garlic consumption and cancer prevention: Meta-analyses of colorectal and stomach cancers
93. Alternative therapies: Part II. Congestive heart failure and hypercholesterolemia
94. Modification of methylmercury neurotoxicity by vitamin E
95. Detoxification of mercury by selenium by binding of equimolar Hg-Se complex to a specific plasma protein
96. Status of mercury and selenium in dental personnel: Impact of amalgam work and own fillings
97. Selenium and its protection against the effects of mercury and silver
98. Structural basis of the antagonism between inorganic mercury and selenium in mammals
99. Thiol and redox reactive agents exert different effects on glutathione metabolism in HeLa cell cultures
100. Homozygous gene deletions of the glutathione S-transferases M1 and T1 are associated with thimerosal sensitization
101. Mutagenicity of mercury chloride and mechanisms of cellular defence: The role of metal-binding proteins
102. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species
103. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress
104. Protective role of DL-alpha-lipoic acid against mercury-induced neural lipid peroxidation
105. N-acetylcysteine as an antidote in methylmercury poisoning
106. Mercury excretion and intravenous ascorbic acid
107. Interactions of vitamin C with lead and mercury
108. Effects of ascorbic acid deficiency on methyl mercury dicyandiamide toxicosis in guinea pigs
109. A relationship between vitamin B12, folic acid, ascorbic acid, and mercury uptake and methylation
110. Increased vulnerability of neurones and glial cells to low concentrations of methylmercury in a prooxidant situation
111. Global outlook on nutrition and the environment: Meeting the challenges of the next millennium
112. Functions of hyaluronan in wound repair
113. Hyaluronan: Fundamental principles and applications in cancer
114. Novel and established applications of microbial polysaccharides
115. The chondrocyte pericellular matrix: A model for hyaluronan-mediated cell-matrix interactions